Nothing Special   »   [go: up one dir, main page]

Braakman et al., 1991 - Google Patents

Expression of CD45 isoforms by fresh and activated human γδ T lymphocytes and natural killer cells

Braakman et al., 1991

Document ID
17864341036541764999
Author
Braakman E
Sturm E
Vijverberg K
van Krimpen B
Gratama J
Bolhuis R
Publication year
Publication venue
International immunology

External Links

Snippet

Naive and primed αβ T cells can be distinguished on the basis of their differential expression of CD45RA and CD45RO, respectively. The present study indicates that these CD45- isoforms also identify naive and primed maturational stages of γδ T cells and natural killer …
Continue reading at academic.oup.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system

Similar Documents

Publication Publication Date Title
Phillips et al. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy.
Galy et al. Precursors of CD3+ CD4+ CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development.
Meuer et al. T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation.
Barcena et al. Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T-and myeloid-cell development
Wright et al. Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.
d'Angeac et al. CD57+ T lymphocytes are derived from CD57− precursors by differentiation occurring in late immune responses
US20090208471A1 (en) Isolation and Use of Human Regulatory T Cells
Braakman et al. Expression of CD45 isoforms by fresh and activated human γδ T lymphocytes and natural killer cells
Spits et al. Functional and phenotypic differences between CD4+ and CD4-T cell receptor-gamma delta clones from peripheral blood.
Muench et al. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver
Denning et al. Human postnatal CD4-CD8-CD3-thymic T cell precursors differentiate in vitro into T cell receptor delta-bearing cells.
Vandekerckhove et al. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse.
Knobloch et al. Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency.
Michon et al. Induction of natural killer effectors from human thymus with recombinant IL-2.
Moretta et al. Human T cell subpopulations defined by a monoclonal antibody. II. Evidence for cell cooperation in the response to alloantigens and generation of cytolytic cells.
Koide et al. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma, delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
Cicuttini et al. A novel population of natural killer progenitor cells isolated from human umbilical cord blood.
Sosman et al. Specific recognition of human leukemic cells by allogeneic T cell lines
JP2006122054A (en) Population of cells enriched for myeloid and/or lymphoid progenitors, and methods of making and using
Aparicio et al. Isolation and characterization of (gamma, delta) CD4+ T cell clones derived from human fetal liver cells.
Barcena et al. A role for interleukin 4 in the differentiation of mature T cell receptor gamma/delta+ cells from human intrathymic T cell precursors.
Haagen et al. The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2
Richards et al. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression
Kusunoki et al. Evidence for in vivo clonal proliferation of unique population of blood CD4-/CD8-T cells bearing T-cell receptor alpha and beta chains in two normal men
Van de Griend et al. In vitro expansion and analysis of cloned cytotoxic T cells derived from patients with chronic T gamma lymphoproliferative disorders